Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Colombo

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Critical Care Explorations|July 19, 2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial CohortChristopher J Colombo, Rhonda E Colombo, Ryan C Maves, et al.
Open Forum Infectious Diseases|December 8, 2021
Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19Ryan C Maves, Stephanie A Richard, David A Lindholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
The Journal of Infectious Diseases|July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Open Forum Infectious Diseases|February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During InfectionF Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Critical Care Explorations|July 19, 2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial CohortChristopher J Colombo, Rhonda E Colombo, Ryan C Maves, et al.
Open Forum Infectious Diseases|December 8, 2021
Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19Ryan C Maves, Stephanie A Richard, David A Lindholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
The Journal of Infectious Diseases|July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Open Forum Infectious Diseases|February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During InfectionF Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Pageof 5